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The term "apoptosis" is derived from the Greek words "απο" and "πτωσιζ" 





Morphological alterations of  apoptotic cell death that 
concern both the nucleus and the cytoplasm are 
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remarkably similar across cell types 
and species
chromatin condensation and nuclear 
fragmentation,
which are accompanied by
1)rounding up of  the cell,
2)reduction in cellular volume (pyknosis)
3)retraction of  pseudopodes
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Morphological hallmarks of  
apoptosis in the nucleus are
Chromatin condensation starts at the 
periphery of  the 
1)nuclear membrane, 




9The chromatin further 
condenses
until it breaks up inside a cell 
with an intact membrane, a 
feature described as 
karyorrhexis
Introduction
he plasma membrane is
intact throughout the total 
process
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At the later stage of  apoptosis some of  the morphological features include
1)membrane blebbing
2) ultrastrutural modification of
cytoplasmic organelle




Biochemical changes in apoptosis
1) activation of  caspases, 
2) DNA and protein breakdown and





here is expression of  phosphatidylserine (PS) in the outer layers of  the cell membrane
which has been "flipped out" from the inner layers. This allows early recognition of  dead cells by 
macrophages,
resulting in phagocytosis without the release of  pro-inflammatory cellular components
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13
This is followed by a 
characteristic
breakdown of  DNA into







internucleosomal cleavage of  DNA
Introduction
into oligonucleosomes in multiples of
180 to 200 base pairs by 
Endonucleases(2)
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Another specific feature of
apoptosis is the activation of  a group of  enzymes belonging to
to the cysteine protease family named caspases. 
The "c" of  "caspase" refers to a cysteine protease, while the "aspase" 





Activated caspases 1)cleave many vital cellular proteins
2)and break up the nuclear scaffold
and cytoskeleton. 
3)They also activate DNAase, which 
further degrade nuclear DNA(3)
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Introduction
Mechanisms of  apoptosis
. Caspases are central to the mechanism of  apoptosis as 
they are both the 
initiators and executioners
There are three pathways by which
caspases can be activated
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2) and extrinsic (or death receptor)
3)A third less well-known initiation 





The extrinsic death receptor pathway
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Introduction
The extrinsic death receptor pathway
the best known death receptors is 
the type
1 TNF receptor (TNFR1)
and a related protein called Fas 
(CD95) 
and their ligands are called 






1)intracellular death domain that recruits adapter 
proteins such as TNF receptor-
2)associated death domain (TRADD) and 
3)Fas-associated death domain (FADD), as well as 
cysteine proteases like caspase 8
The extrinsic death receptor pathway
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Introduction
the whole ligand-receptor-adaptor 
protein complex is known as
the death-inducing signalling complex 
(DISC)
DISC then initiates the 
assembly 
and activation of  pro-caspase 8
The extrinsic death receptor pathway
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3)extremely high concentrations of  
cytosolic Ca2+
4 )and severe oxidative stress are some 
triggers of  the initiation of  the intrinsic 
mitochondrial pathwa




of  the 
stimuli
this pathway is the result of
increased mitochondrial permeability
and the release 
of  pro-apoptotic molecules such as 
cytochrome-c into the cytoplasm
The intrinsic mitochondrial pathway
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Introduction
This pathway is closely regulated by a 
group of  proteins belonging to the 
Bcl-2 family, named after the BCL2 
gene originally observed at the
chromosomal breakpoint of  the 
translocation of  chromosome 18 to 14
in follicular non-Hodgkin lymphoma
The intrinsic mitochondrial pathway
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Introduction
There are two main 
groups of  the Bcl-2
proteins
1)namely the pro-apoptotic
proteins (e.g. Bax, Bak, Bad, 
Bcl-XBs, id, Bik, Bim and 
Hrk)
2)and the anti-apoptotic 
proteins (e.g. Bcl-2, Bcl-XL, 
Bcl-W, Bfl-1 and Mcl-1)
The intrinsic mitochondrial pathway
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Introduction
Other apoptotic factors that
are released from the mitochondrial 
intermembrane space into the cytoplasm include
1)apoptosis inducing factor (AIF)
2) second mitochondria-derived activator of  caspase 
(Smac)
3) direct IAP Binding protein with Low pI 
(DIABLO) 
4)and Omi/high temperature requirement protein A 
(HtrA2)




cytochrome c activates caspase 3 via the 
formation of  





The intrinsic mitochondrial pathway
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Introduction
The intrinsic mitochondrial pathway
Smac/DIABLO or Omi/HtrA2
promotes caspase activation by
binding to inhibitor of  apoptosis 
proteins (IAPs) 
which subsequently leads to disruption 




The intrinsic endoplasmic reticulum pathway
It is believed to be 
caspase 12-dependent
and mitochondria-independent





















Cancer therapy via 
The extrinsic death receptor pathway
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RhApo2L/TRAIL effectively 
induces apoptosis in vitro in a broad

















single-agent activity in 




In the first of  two studies, 
cynomolgus monkeys were 
administered
rhApo2L/TRAIL at doses of.











Preclinical Safety of  
rhApo2L/TRAIL
no evidence of  toxicity to any 
other
major organ system or tissue was 
detected.(6)
Neither detectable signs of  







Activity of  rhApo2L/TRAIL and rituximab
1)Mice (n = 12 mice/group) were then treated 
with vehicle (black x),
2)60 mg/kg rhApo2L/TRAIL (closed blue 
circle), 
3)4 mg/kg rituximab (open green triangle), 
4)10 mg/kg rituximab (open red square),
5)rhApo2L/TRAIL and 4 mg/kg rituximab 
(closed green triangle),
6)or rhApo2L/TRAIL and 10 mg/kg rituximab 
(closed red square).
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The intrinsic mitochondrial pathway
Cancer therapy via 
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Oxidative stress is a 
biochemical condition 
that is












are organic or inorganic molecules




2)reactive nitrogen species (RNS),









The biological functions of  
oxidative stress 
and its




have been investigated for 
several decades.








GPX and SOD activities 
significantly




It is well established that 
some chemotherapeutic












which affect nucleic acids (e.g., 
doxorubicin,
bleomycin) 
3)platinum compounds (e.g., cisplatin)




BCL2 is known to
Discussion
bcl2
1)prevent programmed cell death
2)increase
metastatic potential











High expression of  the 
BCL2 proto-oncogene is















results of  a phase I dose-





One of  the most advanced gene 
therapy agents used in the
treatment of  human cancer is
the replication-
incompetent
adenovirus that delivers 






Preclinical studies in human cell 
lines and





p53 gene contained in RPR/INGN201 is 
efficiently





growth in animal xenografts of  
human SCCHN through the
apoptotic pathway and other 




inhibited cell growth in human 
SCCHN










caspase-8 is mutated in 
different
types of  cancers
Soung and colleagues94 screened gastric
carcinomas (162 cases),
breast carcinomas (93 caspase),
non–
small cell lung cancers (NSCLC) (185 cases), 
and 88 acute
leukaemias (88 cases)
for mutations within the caspase-8 gene










the incidence of  caspase-8 
mutation in gastric cancer is






Furthermore, all of  the 13 
mutations detected
were in advanced gastric 








3)five frameshift mutations in the coding sequences;
……………………………………….
4)two
mutations in the initiation codon; 
……………………………………..
5)three mutations in the






Pancreatic cancer is one of  the 
leading causes of  cancer related















2)and aberrant expression of  FasL
and this mechanism may contribute to 
the malignant
and often rapid course of  the disease
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caspase-3 was mutated in one 
case in
1)stomach adenocarcinoma
2)one case in lung cancer,
3)four cases in
colon cancer,













3)two mutations in the introns,
4)one mutation in the 59-untranslated 
region, 
5)and one mutation
in the 39-untranslated region.
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Caspase-9 is a virtually 
ubiquitous protease, 
constitutively
expressed in a variety of  fetal 
and adult human tissues
Mutational analysis 







mutations were detected in two 





They isolated genomic 
DNAs from normal and
tumour tissues of  the same 
patients
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In a case–control study, 
lung cancer patients and age and
gender matched healthy controls 
were investigated for caspase-9







They reported that the
-21263 GG genotype 
was associated with a 
significantly
decreased risk of  lung cancer 
compared with the -21263 AA 
or
the combined 21263 AA + AG 
genotype
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They found that caspase-9
polymorphisms were significantly associated with the 
risk of
lung cancer in the smokers but not in the non-smokers, which






Such an interaction is
biologically plausible because 
smoking is a major risk factor 
for
lung cancer. 
It was also found that the association 
between
caspase-9 polymorphisms and the risk 
of  lung cancer was
statistically significant in the light 




Most of  what we know about apoptosis has been 
developed
and understood only recentlyThe core idea of
designing therapeutic drugs for cancer is based on the 
fact that
worn out or damaged cells commit suicide in order for 
the body
to continue to grow normally, maintaining a healthy 
number of





we are still left with huge challenges to be 
overcome.
Development of  drugs that act either by 
blocking the action of





or by halting, hampering or
interference with the transcription of  RNA, such 
as small
interfering RNA, BH3 mimetic and some 
HDACi, holds robust
potential for use in cancer therapy; however, the 
hope to cure
cancer is yet to be seen
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